Reuters logo
BRIEF-Amicus Therapeutics receives rare pediatric disease designation for SD-101 for patients with epidermolysis bullosa
2017年5月31日 / 中午11点43分 / 6 个月前

BRIEF-Amicus Therapeutics receives rare pediatric disease designation for SD-101 for patients with epidermolysis bullosa

May 31 (Reuters) - Amicus Therapeutics Inc

* Amicus Therapeutics receives rare pediatric disease designation for SD-101 for patients with epidermolysis bullosa

* Amicus Therapeutics Inc - ‍top-line phase 3 data on track for 3Q17​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below